Column GROUP Iii-a, L.P., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 225,204 shares at $14.95 ($3.4M) on 2020-04-08, disclosed to the SEC on 2020-04-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.95 | 112,602 | $1.7M | 50.0% |
| 2 | $14.95 | 112,602 | $1.7M | 50.0% |
| Total | $14.95 avg | 225,204 | $3.4M | 100% |
| Filing → |
| SRZN | BUY | 2024-04-17 | $6.0M | — | Filing → |
| TNYA | BUY | 2024-02-14 | $10.0M | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |